Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer

15 May 2007

Abstract excerpt

INTRODUCTION: Gene expression profiling of breast carcinomas has increased our understanding of the heterogeneous biology of this disease and promises to impact clinical care. The aim of this study was to evaluate the prognostic value of gene expression-based classification along with established prognostic markers and mutation status of the TP53 gene (tumour protein p53) in a group of breast cancer patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Breast Cancer Treatment Studies
Share to Cancer-related Molecular Pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17504517
DOI: 10.1186/bcr1675

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancerPMID 17504517Read ↗

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.Semantic proximity Read ↗

Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis.Semantic proximity Read ↗

The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancersSemantic proximity Read ↗

Integrated Analysis of p53 Immunohistochemical Expression and TP53 Sequencing for Prognostic Assessment of Triple Negative Breast Cancer After Neoadjuvant ChemotherapySemantic proximity Read ↗

p53 oncoprotein as a prognostic indicator in patients with breast cancer.Semantic proximity Read ↗

Relation between p53 overexpression and established prognostic factors in breast cancer.Semantic proximity Read ↗

Bringing molecular prognosis and prediction to the clinic.Semantic proximity Read ↗

TP53Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast CancerSemantic proximity Read ↗

The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome.Semantic proximity Read ↗

A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients.Semantic proximity Read ↗

Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients.Semantic proximity Read ↗

The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.